Affiance Financial’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-231
Closed -$9.39K 162
2022
Q4
$9.39K Buy
+231
New +$9.39K ﹤0.01% 305